Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.

Journal:

Journal of Clinical Oncology

Published:

2025-07-10

DOI:

10.1200/jco-24-02697

Affiliations:

54

Authors:

35

Go to article

Institutions	Authors	Share
IRCCS European Institute of Oncology (IEO), Italy	2.500000	0.07
International Breast Cancer Study Group (IBCSG), Switzerland	1.500000	0.04
Institute Jules Bordet, ULB, Belgium	1.500000	0.04
Breast International Group (BIG), Belgium	1.500000	0.04
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	1.200000	0.03
Institute of Oncology Ljubljana, Slovenia	1.000000	0.03
NIH National Cancer Institute (NCI), United States of America (USA)	1.000000	0.03
Oslo University Hospital (OUS), Norway	1.000000	0.03
Cairo Cure Oncology Center, Egypt	1.000000	0.03
NYU Laura and Isaac Perlmutter Cancer Center, United States of America (USA)	1.000000	0.03
Soul Reconnect, Spain	1.000000	0.03
Cleveland Clinic Taussig Cancer Center, United States of America (USA)	1.000000	0.03
St. Luke's International Hospital, Japan	1.000000	0.03
University of Colorado Cancer Center, United States of America (USA)	1.000000	0.03
Center Hospital of National Center for Global Health and Medicine, Japan	1.000000	0.03
Institute of Oncology and Radiology of Serbia (IORS), Serbia	1.000000	0.03
Cancer Institute Hospital, JFCR, Japan	1.000000	0.03
Centre Oscar Lambret, France	1.000000	0.03
Champalimaud Foundation, Portugal	1.000000	0.03
IBCSG - U.S.A., United States of America (USA)	0.700000	0.02
Harvard Medical School (HMS), United States of America (USA)	0.700000	0.02
Sungkyunkwan University (SKKU), South Korea	0.500000	0.01
Leiden University Medical Center (LUMC), Netherlands	0.500000	0.01
Spanish Research Group on Breast Cancer (GEICAM), Spain	0.500000	0.01
BC Cancer Agency (BCCA), PHSA, Canada	0.500000	0.01
The University of British Columbia (UBC), Canada	0.500000	0.01
Royal Melbourne Hospital (RMH), Australia	0.500000	0.01
The University of Melbourne (UniMelb), Australia	0.500000	0.01
Dutch Breast Cancer Research Group, Netherlands	0.500000	0.01
Vall d'Hebron University Hospital (HUVH), ICS, Spain	0.500000	0.01
Virgen del Rocío University Hospital, Spain	0.500000	0.01
Samsung Medical Center (SMC), South Korea	0.500000	0.01
SOLTI Breast Cancer Research Group, Spain	0.500000	0.01
Helios Universitätsklinikum Wuppertal, Germany	0.333333	0.01
Witten/Herdecke University (UW/H), Germany	0.333333	0.01
Hôpital Femme Mère Enfant (HFME), HCL, France	0.333333	0.01
RESearch on HealthcAre PErformance (RESHAPE), France	0.333333	0.01
Cancer Trials Ireland, Ireland	0.333333	0.01
St. Vincent's University Hospital, Ireland	0.333333	0.01
Austrian Breast and Colorectal Cancer Study Group (ABCSG), Austria	0.333333	0.01
Tallaght Hospital, Ireland	0.333333	0.01
Catholic University of Leuven (KU Leuven), Belgium	0.333333	0.01
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Netherlands	0.333333	0.01
Geneva University Hospitals (HUG), Switzerland	0.333333	0.01
Swiss Group for Clinical Cancer Research (SAKK), Switzerland	0.333333	0.01
Centre Léon Bérard (CLB), France	0.333333	0.01
University Hospitals Leuven (UZ Leuven), Belgium	0.333333	0.01
Università della Svizzera Italiana (USI), Switzerland	0.333333	0.01
Frontier Science Foundation, United States of America (USA)	0.200000	0.01
Harvard University, United States of America (USA)	0.200000	0.01

Interested in Public Health?